Literature DB >> 28510330

Rhesus Macaque iPSC Generation and Maintenance.

Ravi Chandra Yada1, So Gun Hong1, Yongshun Lin2, Thomas Winkler1, Cynthia E Dunbar1.   

Abstract

The rhesus macaque (Macaca mulatta) is physiologically and phylogenetically similar to humans, and therefore represents an invaluable model for the pre-clinical assessment of the safety and feasibility of iPSC-derived cell therapies. The use of an excisable polycistronic lentiviral STEMCCA vector to reprogram rhesus fibroblasts or bone marrow stromal cells (BMSCs) into RhiPSCs is described. After reprogramming, the pluripotency transgenes can be removed by transient expression of Cre, leaving a residual genetic tag that may be useful for identification of RhiPSC-derived tissues in vivo. Finally, the steps to maintain pluripotency during passaging of RhiPSCs, required for successful utilization of RhiPSCs, is described. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  induced pluripotent stem cells (iPSCs); non-human primate; reprogramming; rhesus macaque

Mesh:

Substances:

Year:  2017        PMID: 28510330      PMCID: PMC5434708          DOI: 10.1002/cpsc.25

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  14 in total

1.  Isolation and characterization of novel rhesus monkey embryonic stem cell lines.

Authors:  Shoukhrat Mitalipov; Hung-Chih Kuo; James Byrne; Lisa Clepper; Lorraine Meisner; Julie Johnson; Renee Zeier; Don Wolf
Journal:  Stem Cells       Date:  2006-06-01       Impact factor: 6.277

2.  Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.

Authors:  Hiroshi Ban; Naoki Nishishita; Noemi Fusaki; Toshiaki Tabata; Koichi Saeki; Masayuki Shikamura; Nozomi Takada; Makoto Inoue; Mamoru Hasegawa; Shin Kawamata; Shin-Ichi Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-05       Impact factor: 11.205

3.  Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.

Authors:  Randall K Merling; Colin L Sweeney; Uimook Choi; Suk See De Ravin; Timothy G Myers; Francisco Otaizo-Carrasquero; Jason Pan; Gilda Linton; Lifeng Chen; Sherry Koontz; Narda L Theobald; Harry L Malech
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

4.  The Role of Nonhuman Primate Animal Models in the Clinical Development of Pluripotent Stem Cell Therapies.

Authors:  So Gun Hong; Yongshun Lin; Cynthia E Dunbar; Jizhong Zou
Journal:  Mol Ther       Date:  2016-08       Impact factor: 11.454

5.  Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.

Authors:  Penelope J Hallett; Michela Deleidi; Arnar Astradsson; Gaynor A Smith; Oliver Cooper; Teresia M Osborn; Maria Sundberg; Michele A Moore; Eduardo Perez-Torres; Anna-Liisa Brownell; James M Schumacher; Roger D Spealman; Ole Isacson
Journal:  Cell Stem Cell       Date:  2015-02-26       Impact factor: 24.633

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.

Authors:  Marina E Emborg; Yan Liu; Jiajie Xi; Xiaoqing Zhang; Yingnan Yin; Jianfeng Lu; Valerie Joers; Christine Swanson; James E Holden; Su-Chun Zhang
Journal:  Cell Rep       Date:  2013-03-14       Impact factor: 9.423

8.  Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector.

Authors:  Cesar A Sommer; Andreia Gianotti Sommer; Tyler A Longmire; Constantina Christodoulou; Dolly D Thomas; Monica Gostissa; Fred W Alt; George J Murphy; Darrell N Kotton; Gustavo Mostoslavsky
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

9.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

10.  Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.

Authors:  So Gun Hong; Thomas Winkler; Chuanfeng Wu; Vicky Guo; Stefania Pittaluga; Alina Nicolae; Robert E Donahue; Mark E Metzger; Sandra D Price; Naoya Uchida; Sergei A Kuznetsov; Tina Kilts; Li Li; Pamela G Robey; Cynthia E Dunbar
Journal:  Cell Rep       Date:  2014-05-15       Impact factor: 9.423

View more
  2 in total

1.  CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes.

Authors:  John W Ostrominski; Ravi Chandra Yada; Noriko Sato; Michael Klein; Ksenia Blinova; Dakshesh Patel; Racquel Valadez; Maryknoll Palisoc; Stefania Pittaluga; Kah-Whye Peng; Hong San; Yongshun Lin; Falguni Basuli; Xiang Zhang; Rolf E Swenson; Mark Haigney; Peter L Choyke; Jizhong Zou; Manfred Boehm; So Gun Hong; Cynthia E Dunbar
Journal:  Stem Cells Transl Med       Date:  2020-07-23       Impact factor: 6.940

2.  Non-Human Primate iPSC Generation, Cultivation, and Cardiac Differentiation under Chemically Defined Conditions.

Authors:  Michael Stauske; Ignacio Rodriguez Polo; Wadim Haas; Debbra Yasemin Knorr; Thomas Borchert; Katrin Streckfuss-Bömeke; Ralf Dressel; Iris Bartels; Malte Tiburcy; Wolfram-Hubertus Zimmermann; Rüdiger Behr
Journal:  Cells       Date:  2020-05-29       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.